An evaluation of serologic and antimicrobial therapy in the treatment of tetanus in the United States.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000992:Antitoxins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance; D013742:Tetanus / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality; D014481:United States; D005719:gamma-Globulins / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D000992:Antitoxins; D005719:gamma-Globulins